| 2.1 |
8.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 1.7 |
53.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.7 |
5.1 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 1.6 |
4.8 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.5 |
4.6 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 1.5 |
5.9 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 1.4 |
7.0 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.3 |
5.4 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 1.3 |
5.1 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 1.2 |
7.3 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 1.1 |
11.8 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 1.1 |
3.2 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 1.1 |
5.3 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 1.0 |
3.1 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 1.0 |
3.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.0 |
3.1 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.0 |
3.0 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 1.0 |
3.0 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 1.0 |
8.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.9 |
2.8 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.9 |
3.7 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.9 |
0.9 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.9 |
3.7 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.9 |
2.8 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.9 |
2.7 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.9 |
2.6 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.9 |
5.2 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.9 |
1.7 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.9 |
8.5 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.8 |
3.4 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.8 |
17.6 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.8 |
0.8 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.8 |
2.5 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.8 |
2.5 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.8 |
9.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.8 |
2.4 |
GO:0003223 |
ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.8 |
3.2 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.8 |
2.4 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.8 |
13.4 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.8 |
3.9 |
GO:0035247 |
peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.8 |
0.8 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.8 |
1.5 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.8 |
3.1 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.8 |
0.8 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.8 |
3.8 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.7 |
0.7 |
GO:0006901 |
vesicle coating(GO:0006901) |
| 0.7 |
1.5 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.7 |
5.9 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.7 |
2.2 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.7 |
2.2 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.7 |
2.9 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.7 |
2.2 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.7 |
3.6 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.7 |
2.1 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.7 |
4.9 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.7 |
2.1 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.7 |
4.9 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.7 |
2.8 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.7 |
2.1 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.7 |
3.4 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.7 |
2.0 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.7 |
2.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.7 |
15.9 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.7 |
2.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.6 |
4.5 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.6 |
2.6 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.6 |
1.9 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.6 |
1.9 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.6 |
1.9 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.6 |
0.6 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.6 |
1.9 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.6 |
7.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.6 |
0.6 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.6 |
6.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.6 |
1.2 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.6 |
2.5 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.6 |
1.8 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.6 |
1.8 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.6 |
0.6 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.6 |
1.8 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.6 |
6.0 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.6 |
1.2 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.6 |
3.0 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.6 |
2.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.6 |
1.8 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.6 |
2.3 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.6 |
8.0 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.6 |
1.1 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.6 |
3.4 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.6 |
3.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.6 |
5.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.6 |
0.6 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.5 |
1.6 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.5 |
8.2 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.5 |
2.2 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.5 |
3.2 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.5 |
2.1 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 |
0.5 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.5 |
2.1 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.5 |
2.1 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.5 |
1.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.5 |
2.6 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.5 |
1.5 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.5 |
1.5 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.5 |
1.0 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.5 |
1.0 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) |
| 0.5 |
2.0 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.5 |
1.0 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.5 |
4.0 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 0.5 |
2.5 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.5 |
1.5 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.5 |
1.0 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.5 |
1.0 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.5 |
1.5 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.5 |
2.4 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.5 |
6.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.5 |
1.0 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.5 |
2.9 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.5 |
1.9 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.5 |
0.5 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 |
1.4 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.5 |
1.4 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.5 |
3.8 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.5 |
1.9 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.5 |
1.9 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.5 |
1.9 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.5 |
3.3 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.5 |
1.4 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.5 |
0.5 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.5 |
3.7 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.5 |
2.3 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.5 |
1.4 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.5 |
2.7 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.5 |
0.5 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.5 |
1.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.5 |
4.5 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.5 |
1.8 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.4 |
1.8 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.4 |
5.3 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.4 |
2.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.4 |
22.9 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.4 |
0.4 |
GO:2000277 |
positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 0.4 |
4.4 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.4 |
1.3 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.4 |
1.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.4 |
3.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.4 |
1.3 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.4 |
1.3 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 |
0.4 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.4 |
1.7 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.4 |
0.9 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.4 |
0.4 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.4 |
6.8 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.4 |
3.8 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.4 |
1.7 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.4 |
5.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.4 |
6.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.4 |
2.1 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.4 |
1.3 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 |
0.8 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.4 |
2.5 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.4 |
1.7 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.4 |
1.2 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.4 |
0.8 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.4 |
0.4 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.4 |
1.2 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
| 0.4 |
14.7 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.4 |
0.8 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.4 |
1.6 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.4 |
0.4 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.4 |
0.8 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.4 |
2.4 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.4 |
1.2 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.4 |
0.4 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.4 |
2.4 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.4 |
0.8 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.4 |
1.2 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 0.4 |
2.0 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.4 |
1.2 |
GO:1902074 |
response to salt(GO:1902074) |
| 0.4 |
1.6 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.4 |
6.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.4 |
1.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.4 |
5.5 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.4 |
0.8 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.4 |
2.0 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.4 |
0.8 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.4 |
1.2 |
GO:2000562 |
positive regulation of defense response to bacterium(GO:1900426) negative regulation of interferon-gamma secretion(GO:1902714) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.4 |
1.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 |
3.9 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.4 |
36.1 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.4 |
0.8 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.4 |
1.2 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.4 |
5.7 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.4 |
2.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.4 |
1.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.4 |
0.4 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.4 |
1.1 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.4 |
1.1 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.4 |
1.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.4 |
1.1 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.4 |
1.1 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.4 |
2.6 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.4 |
3.3 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 0.4 |
2.2 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.4 |
9.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.4 |
1.1 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 0.4 |
2.9 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.4 |
3.6 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.4 |
1.4 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.4 |
1.1 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.4 |
1.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
1.4 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.4 |
2.1 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.4 |
1.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 |
0.7 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.3 |
1.4 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.3 |
1.4 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.3 |
0.7 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
1.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
2.1 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.3 |
0.7 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.3 |
1.0 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
1.0 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
1.4 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.3 |
7.4 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 |
1.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
4.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.3 |
1.6 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
| 0.3 |
6.6 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.3 |
1.3 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.3 |
2.6 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.3 |
1.0 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.3 |
1.6 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 |
3.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.3 |
6.4 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 |
3.5 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.3 |
0.6 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.3 |
2.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.3 |
1.0 |
GO:0032910 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
| 0.3 |
0.6 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.3 |
1.6 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 |
1.9 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.3 |
0.9 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.3 |
3.7 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.3 |
1.5 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 |
0.3 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.3 |
0.9 |
GO:0046032 |
ADP catabolic process(GO:0046032) |
| 0.3 |
1.8 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.3 |
0.9 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.3 |
4.6 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.3 |
0.9 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.3 |
2.1 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 |
0.6 |
GO:0006106 |
fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) |
| 0.3 |
1.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.3 |
1.5 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.3 |
3.0 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 |
0.9 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.3 |
1.5 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.3 |
1.2 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.3 |
5.0 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.3 |
3.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.3 |
0.3 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.3 |
5.0 |
GO:1901663 |
quinone biosynthetic process(GO:1901663) |
| 0.3 |
0.6 |
GO:1903243 |
negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.3 |
0.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 |
0.6 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.3 |
0.9 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.3 |
0.9 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 |
0.3 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.3 |
0.6 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.3 |
5.8 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
0.9 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
2.0 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.3 |
1.4 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
1.4 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.3 |
2.0 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.3 |
2.6 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.3 |
5.6 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.3 |
1.4 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.3 |
1.7 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.3 |
2.0 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 |
0.3 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.3 |
1.1 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.3 |
1.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.3 |
1.4 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.3 |
1.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.3 |
1.4 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.3 |
0.5 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 |
1.6 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.3 |
4.1 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.3 |
0.8 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.3 |
4.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.3 |
4.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.3 |
1.1 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.3 |
0.8 |
GO:0051311 |
spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
| 0.3 |
0.8 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.3 |
1.4 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.3 |
0.3 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.3 |
0.5 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.3 |
1.0 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.3 |
5.0 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.3 |
0.3 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.3 |
1.0 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
0.8 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.3 |
1.5 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.3 |
1.5 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.3 |
0.3 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.3 |
0.5 |
GO:0045950 |
telomeric loop formation(GO:0031627) negative regulation of mitotic recombination(GO:0045950) |
| 0.3 |
2.3 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.3 |
2.0 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
0.8 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.3 |
0.5 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.3 |
2.0 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.3 |
2.8 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.3 |
1.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.3 |
0.3 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.2 |
0.7 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.2 |
0.2 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.2 |
1.0 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.2 |
0.2 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
0.7 |
GO:0000279 |
mitotic M phase(GO:0000087) M phase(GO:0000279) mitotic cell cycle phase(GO:0098763) |
| 0.2 |
0.7 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 |
0.2 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.2 |
0.5 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.2 |
0.2 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.2 |
1.2 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.2 |
1.4 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.2 |
2.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
0.2 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.2 |
0.9 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
0.7 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 |
0.5 |
GO:2000173 |
negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 |
3.1 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.2 |
0.5 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.2 |
1.6 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.2 |
0.7 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.2 |
0.7 |
GO:1902165 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.2 |
1.4 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 |
1.2 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.2 |
2.5 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 |
8.1 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.2 |
0.5 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.2 |
1.3 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.2 |
0.4 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 |
1.8 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
4.0 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
0.9 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
1.1 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
0.7 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 |
4.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
0.7 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.2 |
3.5 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.2 |
3.3 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
0.7 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
0.4 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.2 |
0.9 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 |
0.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
0.4 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 0.2 |
0.4 |
GO:0007320 |
insemination(GO:0007320) |
| 0.2 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
0.8 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.2 |
1.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.6 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 |
5.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
1.7 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.2 |
2.1 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.2 |
10.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
1.6 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.2 |
1.4 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
1.0 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.2 |
2.0 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.2 |
0.6 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.2 |
1.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.2 |
0.8 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.2 |
0.6 |
GO:1902277 |
pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.2 |
2.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.2 |
0.6 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 |
0.6 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
1.2 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
0.6 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
1.2 |
GO:0015669 |
gas transport(GO:0015669) |
| 0.2 |
1.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.2 |
1.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
0.6 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.2 |
1.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 |
1.3 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 |
1.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
4.2 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
0.6 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
0.8 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.2 |
0.8 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.2 |
0.8 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
4.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
0.7 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.2 |
0.9 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 |
2.4 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
0.2 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.2 |
0.6 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.2 |
0.9 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.2 |
1.3 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.2 |
0.7 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 |
0.2 |
GO:0035993 |
deltoid tuberosity development(GO:0035993) |
| 0.2 |
1.5 |
GO:0042522 |
regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) |
| 0.2 |
0.6 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.2 |
0.9 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
1.1 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
0.7 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
1.5 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
0.7 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.2 |
0.7 |
GO:0071440 |
regulation of histone H3-K14 acetylation(GO:0071440) |
| 0.2 |
1.6 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.2 |
0.9 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 |
1.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.2 |
2.9 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.2 |
0.5 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.2 |
0.4 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
0.4 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.2 |
1.1 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.2 |
0.4 |
GO:0036336 |
myeloid dendritic cell chemotaxis(GO:0002408) dendritic cell migration(GO:0036336) |
| 0.2 |
1.4 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.2 |
0.3 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.2 |
0.5 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.2 |
1.7 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
0.5 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.9 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.2 |
0.2 |
GO:0033092 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.2 |
0.7 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.2 |
5.5 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.2 |
2.6 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 |
0.2 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
0.5 |
GO:0019740 |
nitrogen utilization(GO:0019740) |
| 0.2 |
0.3 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.2 |
0.5 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
10.6 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.2 |
1.3 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.2 |
0.7 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
2.6 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.2 |
1.2 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.2 |
1.5 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
4.8 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.2 |
1.3 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 |
0.8 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.2 |
1.3 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.2 |
1.1 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.2 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 |
0.8 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.2 |
0.5 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.2 |
0.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 |
2.7 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
1.4 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.2 |
25.1 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.2 |
2.1 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
3.0 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.2 |
3.6 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.2 |
0.9 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.2 |
1.6 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.2 |
0.9 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.2 |
2.0 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.2 |
1.9 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.2 |
0.6 |
GO:0046210 |
growth plate cartilage chondrocyte proliferation(GO:0003419) regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.2 |
0.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
0.5 |
GO:2000484 |
positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.2 |
0.8 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 |
0.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.6 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) fibroblast activation(GO:0072537) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
0.3 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 |
0.6 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.2 |
0.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 |
0.9 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 |
0.3 |
GO:2000832 |
protein-chromophore linkage(GO:0018298) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.2 |
0.3 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.2 |
4.8 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.4 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.1 |
1.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
1.2 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.7 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.9 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
6.5 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
2.5 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
1.2 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 |
0.4 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
2.0 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
1.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.3 |
GO:0043497 |
regulation of protein heterodimerization activity(GO:0043497) |
| 0.1 |
0.4 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.1 |
0.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.1 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.1 |
0.7 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 |
1.8 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
1.4 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
2.0 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.1 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.1 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.8 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.5 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
0.3 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.1 |
0.3 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 |
0.5 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.1 |
0.1 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.1 |
0.4 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.1 |
0.5 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.1 |
0.4 |
GO:0038179 |
neurotrophin signaling pathway(GO:0038179) |
| 0.1 |
1.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
2.9 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.3 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.5 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.1 |
0.9 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.8 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
1.7 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.5 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.5 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.1 |
0.9 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 |
1.3 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.1 |
1.4 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
0.5 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.4 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
1.0 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.6 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.1 |
0.4 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.6 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
0.5 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
| 0.1 |
0.5 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.6 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
1.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.5 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.6 |
GO:0001798 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) positive regulation of inflammatory response to antigenic stimulus(GO:0002863) positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) positive regulation of hypersensitivity(GO:0002885) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 |
0.7 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.7 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.5 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.8 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
0.7 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
3.1 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
1.6 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.1 |
0.4 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.7 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.4 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
2.3 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.1 |
0.6 |
GO:1902170 |
cellular response to reactive nitrogen species(GO:1902170) |
| 0.1 |
0.4 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.7 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.1 |
1.6 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.1 |
1.3 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
1.0 |
GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.1 |
0.6 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.1 |
0.6 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.9 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
0.7 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.7 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.2 |
GO:0002155 |
regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
2.2 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
1.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.4 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
1.8 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.6 |
GO:0009136 |
ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.1 |
0.3 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
0.6 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.6 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 |
0.4 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.1 |
GO:0046385 |
2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
| 0.1 |
0.1 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 |
1.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
1.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.4 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.4 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
0.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.3 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.4 |
GO:0070723 |
response to cholesterol(GO:0070723) cellular response to cholesterol(GO:0071397) |
| 0.1 |
0.4 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.3 |
GO:0060534 |
trachea cartilage development(GO:0060534) |
| 0.1 |
0.4 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.2 |
GO:1902592 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.4 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
3.1 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.4 |
GO:0015786 |
UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
| 0.1 |
1.4 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
2.3 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
0.4 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
0.6 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
0.7 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.1 |
0.1 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.1 |
0.8 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
1.8 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.3 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.4 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.2 |
GO:0048302 |
isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.1 |
0.6 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
1.1 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.1 |
1.0 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 |
0.4 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
0.9 |
GO:0033240 |
positive regulation of cellular amine metabolic process(GO:0033240) |
| 0.1 |
0.9 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.6 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
1.0 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
1.4 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
1.1 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 |
1.4 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.1 |
0.8 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.4 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 |
1.1 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.7 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.1 |
1.5 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 0.1 |
1.6 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.1 |
0.5 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.7 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.1 |
0.3 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 |
1.0 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
0.7 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.1 |
0.5 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
0.8 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.1 |
0.5 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.1 |
0.7 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.1 |
0.3 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.5 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.1 |
2.9 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.6 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.1 |
29.4 |
GO:0006412 |
translation(GO:0006412) |
| 0.1 |
0.3 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
0.2 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
1.3 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.4 |
GO:0086103 |
G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.1 |
0.6 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.1 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.8 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.7 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 |
0.3 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.9 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
0.6 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.8 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.3 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.1 |
0.1 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.1 |
0.3 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
1.0 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.3 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
1.0 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.9 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.5 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.1 |
0.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.4 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
0.3 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 |
1.4 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.4 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.6 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.6 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.1 |
0.2 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.3 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
0.5 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.8 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 |
0.4 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
0.4 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
0.4 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.5 |
GO:1990748 |
cellular detoxification(GO:1990748) |
| 0.1 |
0.2 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.1 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.4 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.2 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.4 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.1 |
0.4 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
| 0.1 |
0.5 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.1 |
0.2 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.1 |
0.4 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.1 |
0.2 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 |
0.6 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.5 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.9 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
0.5 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.9 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.1 |
GO:0010458 |
exit from mitosis(GO:0010458) |
| 0.1 |
0.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.3 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
1.2 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.1 |
0.5 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) |
| 0.1 |
0.9 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.1 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.1 |
1.3 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.1 |
0.6 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.1 |
1.0 |
GO:0043487 |
regulation of RNA stability(GO:0043487) |
| 0.1 |
1.0 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
3.0 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
3.1 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
0.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.4 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.1 |
1.1 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.2 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.1 |
0.9 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.4 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.4 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.1 |
0.1 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.1 |
0.1 |
GO:0060839 |
endothelial cell fate commitment(GO:0060839) positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 |
0.2 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.4 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.5 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.1 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.1 |
0.6 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
0.5 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
0.1 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.1 |
0.4 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
0.8 |
GO:1901343 |
negative regulation of vasculature development(GO:1901343) |
| 0.1 |
0.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
0.2 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.7 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.2 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.1 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.3 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.1 |
0.3 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.1 |
0.3 |
GO:0042053 |
regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
| 0.1 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.7 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.6 |
GO:0006882 |
cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
| 0.1 |
0.6 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
1.1 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
1.0 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.4 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 |
0.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.4 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
0.2 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.1 |
0.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.2 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.1 |
0.2 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
1.0 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.2 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.0 |
0.1 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) L-ascorbic acid metabolic process(GO:0019852) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
0.3 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.0 |
0.1 |
GO:0050932 |
regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
| 0.0 |
0.7 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.4 |
GO:1904262 |
TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.2 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.2 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.4 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.9 |
GO:0060487 |
lung epithelial cell differentiation(GO:0060487) |
| 0.0 |
0.1 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 |
2.1 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
2.3 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.4 |
GO:0071384 |
cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
| 0.0 |
0.8 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
1.1 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.6 |
GO:0014032 |
neural crest cell development(GO:0014032) neural crest cell differentiation(GO:0014033) |
| 0.0 |
0.2 |
GO:1901727 |
positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 |
0.4 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.5 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 |
0.6 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.1 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 |
0.1 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.0 |
0.4 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.7 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.0 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.0 |
0.2 |
GO:0033598 |
mammary gland epithelial cell proliferation(GO:0033598) |
| 0.0 |
0.2 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.0 |
1.7 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 |
0.1 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.2 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.5 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0032105 |
negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.0 |
0.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 |
0.7 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.8 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
0.3 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 |
0.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) regulation of vascular wound healing(GO:0061043) |
| 0.0 |
0.2 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.0 |
0.6 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.1 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 |
0.1 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.0 |
0.3 |
GO:0009262 |
deoxyribonucleotide metabolic process(GO:0009262) |
| 0.0 |
0.4 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.0 |
0.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.3 |
GO:0070203 |
regulation of establishment of protein localization to telomere(GO:0070203) regulation of protein localization to chromosome, telomeric region(GO:1904814) |
| 0.0 |
0.3 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.3 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.0 |
0.3 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.0 |
0.3 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
0.1 |
GO:0071224 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) cellular response to peptidoglycan(GO:0071224) |
| 0.0 |
0.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.0 |
0.4 |
GO:0009206 |
purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.0 |
0.4 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.1 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.0 |
0.2 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.1 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.0 |
0.1 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.1 |
GO:0002577 |
regulation of antigen processing and presentation(GO:0002577) |
| 0.0 |
0.0 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.5 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.2 |
GO:0032594 |
protein transport within lipid bilayer(GO:0032594) |
| 0.0 |
0.0 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 |
0.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.1 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.1 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.5 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.0 |
0.9 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
0.1 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.1 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.2 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.0 |
0.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.0 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.6 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.3 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.0 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.0 |
GO:0044827 |
negative regulation by host of viral process(GO:0044793) modulation by host of viral genome replication(GO:0044827) negative regulation by host of viral genome replication(GO:0044828) |
| 0.0 |
0.3 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.0 |
0.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
0.1 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.1 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.1 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.1 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 |
0.0 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
1.9 |
GO:0009615 |
response to virus(GO:0009615) |
| 0.0 |
0.0 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.0 |
0.1 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.0 |
0.2 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.1 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.0 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.0 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.2 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.1 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.0 |
0.3 |
GO:0006893 |
Golgi to plasma membrane transport(GO:0006893) |
| 0.0 |
0.0 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.0 |
0.1 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
